State Ledger
Company profile

Seres Therapeutics, Inc. CIK 1609809

Ticker
MCRB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, MA 02139
Fiscal year end
2025 (FY)
Market Data
Close
$2.73
Change
+$0.01
Change %
0.18%
Volume
2,114

MCRB · trading date Oct 12, 2026 · previous close $2.72 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$789.0K
Net income
$5.70M
Total assets
$138.19M
Total liabilities
$93.98M
Stockholders' equity
$44.22M
Cash & equivalents
$45.77M
Operating income
-$93.97M
Operating cash flow
$1.12M
Capital expenditures
$252.0K

Fiscal year 2025, via 10-K filed 2026-03-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-11,910.1%
Net margin
721.9%
Free cash flow
$865.0K
Free cash flow margin
109.6%
Liabilities / assets
68.0%
Equity / assets
32.0%
CapEx / revenue
31.9%
Operating cash flow / net income
0.20×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $789.0K $5.70M $138.19M $93.98M $44.22M
2024 $0 $136.0K $139.81M $126.03M $13.78M
2023 $0 -$113.72M $358.60M $403.46M -$44.86M
2022 $7.13M -$250.16M $348.78M $338.00M $10.78M
2021 $144.93M -$65.58M $354.86M $223.35M $131.51M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form EFFECT
2026-08-21
Financials filed via
Form 10-K
filed 2026-03-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cambridge, MA 02139
200 SIDNEY STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies